[go: up one dir, main page]

PE20040678A1 - Moduladores de los receptores selectivos de estrogenos - Google Patents

Moduladores de los receptores selectivos de estrogenos

Info

Publication number
PE20040678A1
PE20040678A1 PE2003000717A PE2003000717A PE20040678A1 PE 20040678 A1 PE20040678 A1 PE 20040678A1 PE 2003000717 A PE2003000717 A PE 2003000717A PE 2003000717 A PE2003000717 A PE 2003000717A PE 20040678 A1 PE20040678 A1 PE 20040678A1
Authority
PE
Peru
Prior art keywords
selective estrogen
modulators
estrogen receptors
leiomyomata
useful
Prior art date
Application number
PE2003000717A
Other languages
English (en)
Inventor
Kin Chiu Fong
Conrad Wilson Hummel
Robert Dean Dally
Scott Alan Jones
Timothy Alan Shepherd
George Sal Lewis
Owen Brendan Wallace
Scott Alan Frank
Jeffrey Alan Dodge
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PE20040678A1 publication Critical patent/PE20040678A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/64—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/72—Benzo[c]thiophenes; Hydrogenated benzo[c]thiophenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SE REFIERE A UN COMPUESTO DE FORMULA I DONDE m, q Y r SON CADA UNO 0-2; n ES 0-1; R ES H O COR2; R0 ES OH, CF3, HALO, ALQUILO C1-C6, ALCOXI C1-C6; R1 Y R1' SON CADA UNO ALQUILO C1-C6, CF3, CH2CF3, ENTRE OTROS; R2 ES ALQUILO C1-C6, ALCOXI C1-C6, FENOXI, ENTRE OTROS; X ES O, CH2, CO; X1 ES O, NH, N(ALQUILO C1-C6); R8 ES H O METILO SI r ES 1-2; Y ES S, CH2CH2, CH=CH. SON COMPUESTOS PREFERIDOS: 1-(2-{4-[2-(4-METANOSULFONIL-FENIL)-6-METOXI-NAFTALEN-1-ILOXI]-FENOXI}-ETIL)-PIPERIDINA; CLORHIDRATO DE 6-(4-METANOSULFONIL-FENIL)-5-[4-(2-PIPERIDIN-1-IL-ETOXI)-FENOXI]-NAFTALEN-2-IL ESTER DEL ACIDO 2,2-DIMETIL-PROPIONICO Y 5-[4-(2-PIPERIDIN-1-IL-ETOXI)FENOXI]-6-4-TRIFLUOROMETANOSULFONIL-FENIL)-NAFTALEN-2-OL. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON UTILES EN EL TRATAMIENTO DE LA ENDOMETRIOSIS UTERINA Y/O LEIOMIOMA/LEIOMIOMATA UTERINO
PE2003000717A 2002-07-22 2003-07-18 Moduladores de los receptores selectivos de estrogenos PE20040678A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39786902P 2002-07-22 2002-07-22
US45023303P 2003-02-25 2003-02-25

Publications (1)

Publication Number Publication Date
PE20040678A1 true PE20040678A1 (es) 2004-10-06

Family

ID=30773044

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2003000717A PE20040678A1 (es) 2002-07-22 2003-07-18 Moduladores de los receptores selectivos de estrogenos

Country Status (24)

Country Link
US (2) US7399867B2 (es)
EP (1) EP1530470B9 (es)
JP (2) JP4656939B2 (es)
CN (1) CN1668303B (es)
AT (1) ATE433322T1 (es)
AU (1) AU2003253129B2 (es)
BR (1) BR0312675A (es)
CA (1) CA2490580C (es)
CO (1) CO5680445A2 (es)
CR (1) CR7657A (es)
DE (1) DE60327931D1 (es)
EA (1) EA008024B1 (es)
EC (1) ECSP055549A (es)
ES (1) ES2326593T3 (es)
HR (1) HRP20041233A2 (es)
IL (1) IL165745A0 (es)
MX (1) MXPA05000898A (es)
MY (1) MY141879A (es)
NO (1) NO20050832L (es)
NZ (1) NZ537138A (es)
PE (1) PE20040678A1 (es)
PL (1) PL374845A1 (es)
TW (1) TWI314860B (es)
WO (1) WO2004009086A1 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0312675A (pt) * 2002-07-22 2005-05-03 Lilly Co Eli Composto ou um sal de adição de ácido farmacêutico do mesmo,m e, métodos para tratar endometriose, e para tratar leiomioma uterino
AU2004216258B2 (en) * 2003-02-25 2006-10-19 Eli Lilly And Company Crystalline non-solvated 1-(4-(2-piperidinylethoxy)phenoxy)-2-(4-methanesulfonylphenyl)-6-hydroxynaphthalene hydrochloride
NZ541126A (en) * 2003-02-25 2008-07-31 Lilly Co Eli Crystalline non-solvated 1-(4-(2-piperidinylethoxy)phenoxy)-2-(4-methanesulfonylphenyl)-6-hydroxynaphthalene hydrochloride
CN1910167B (zh) * 2004-01-22 2011-08-10 伊莱利利公司 用于治疗血管舒缩症状的选择性雌激素受体调节剂
DE602005017577D1 (de) * 2004-01-22 2009-12-24 Lilly Co Eli Selektive östrogen-rezeptor-modulatoren
ATE476428T1 (de) 2004-01-22 2010-08-15 Lilly Co Eli Selektive modulatoren des östrogenrezeptors zur behandlung von vasomotorischen symptomen
EP1713770A1 (en) * 2004-01-29 2006-10-25 Eli Lilly And Company Selective estrogen receptor modulators
WO2006002185A1 (en) * 2004-06-22 2006-01-05 Smithkline Beecham Corporation Chemical compounds
CA2617146A1 (en) * 2005-07-29 2007-02-08 Eli Lilly And Company Crystalline non-solvated methanesulfonic acid salt of 1-(4-(2-piperidinylethoxy)phenoxy)-2-(3-hydroxyphenyl)-6-hydroxynaphthalene
EA020742B1 (ru) * 2008-09-29 2015-01-30 Эли Лилли Энд Компани Селективный модулятор рецепторов эстрогена
DE102008057230A1 (de) * 2008-11-11 2010-05-12 Bayer Schering Pharma Aktiengesellschaft Synergistische pharmazeutische Kombination mit einem Estrogenrezeptorantagonisten und einem Progestin
CA2754685A1 (en) 2009-03-11 2010-09-16 Pfizer Inc. Substituted indazole amides
KR20140089402A (ko) 2010-06-16 2014-07-14 앙도르쉐르슈 인코포레이티드 에스트로겐-관련 질병의 치료 또는 예방 방법
JP6292744B2 (ja) * 2012-09-19 2018-03-14 富士カプセル株式会社 医薬品組成物
CA2899030C (en) 2013-02-19 2021-03-09 Novartis Ag Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders
CN113544125A (zh) 2019-03-08 2021-10-22 先正达农作物保护股份公司 杀有害生物活性的唑-酰胺化合物
CN113631552A (zh) 2019-03-20 2021-11-09 先正达农作物保护股份公司 杀有害生物活性的唑酰胺化合物
US20220213063A1 (en) 2019-03-22 2022-07-07 Syngenta Crop Protection Ag N-[l-(5-BROMO-2-PYRIMIDIN-2-YL-1,2,4-TRIAZOL-3-YL)ETHYL]-2-CYCLOPROPYL-6-(TRIFLUOROMETHYL)PYRIDINE-4-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS INSECTICIDES
TWI853009B (zh) 2019-03-29 2024-08-21 瑞士商先正達農作物保護公司 殺有害生物活性之二-醯胺化合物
CN113661165B (zh) 2019-04-05 2025-05-23 先正达农作物保护股份公司 杀有害生物活性的二嗪-酰胺化合物
US20220289715A1 (en) 2019-08-23 2022-09-15 Syngenta Crop Protection Ag Pesticidally active pyrazine-amide compounds
CN110526881B (zh) * 2019-08-27 2020-09-22 河南省锐达医药科技有限公司 一种萘胺类化合物及其生物学可接受的盐，其制备方法和应用
US20230143596A1 (en) 2020-02-27 2023-05-11 Syngenta Crop Protection Ag Pesticidally active diazine-bisamide compounds
CN117279884A (zh) * 2021-05-14 2023-12-22 江苏亚虹医药科技股份有限公司 一种含萘环的化合物、含其的药物组合物及其应用
EP4352050A1 (en) 2021-06-09 2024-04-17 Syngenta Crop Protection AG Pesticidally active diazine-amide compounds
US20240208950A1 (en) * 2021-07-07 2024-06-27 South Dakota Board Of Regents Compositions and methods for treatment of cervical and ovarian cancer
JP2025526986A (ja) 2022-08-25 2025-08-15 サノフイ 新規な置換ベンゾチオフェン－６－カルボン酸誘導体、その調製方法、及びその治療的使用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
WO1993023374A1 (fr) 1992-05-08 1993-11-25 Otsuka Pharmaceutical Factory, Inc. Derive d'indole
US6756388B1 (en) 1993-10-12 2004-06-29 Pfizer Inc. Benzothiophenes and related compounds as estrogen agonists
US7501441B1 (en) * 1994-09-20 2009-03-10 Eli Lilly And Company Naphthyl compounds, intermediates, processes, compositions, and methods
US5492921A (en) 1994-09-20 1996-02-20 Eli Lilly And Company Benzothiophene compounds, compositions, and methods for inhibiting aortal smooth muscle proliferation
US5552412A (en) 1995-01-09 1996-09-03 Pfizer Inc 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
SG64896A1 (en) 1995-02-28 1999-05-25 Lilly Co Eli Benzothiophene compounds intermediates compositions and methods
US5998401A (en) * 1995-02-28 1999-12-07 Eli Lilly And Company Naphthyl compounds, intermediates, compositions, and methods
US5599822A (en) 1995-06-06 1997-02-04 Eli Lilly And Company Methods for minimizing bone loss
CA2236007A1 (en) * 1995-10-31 1997-07-17 Gerald Floyd Smith Antithrombotic diamines
WO1997030709A1 (en) * 1996-02-22 1997-08-28 Eli Lilly And Company Benzothiophenes, formulations containing same, and methods
ATE206701T1 (de) 1996-04-19 2001-10-15 American Home Prod Östrogene verbindungen
ID19392A (id) 1996-08-29 1998-07-09 Lilly Co Eli Senyawa naftil dan bahan pertengahan serta komposisi dan metode penggunaan
CA2214070C (en) 1996-08-29 2006-03-14 Eli Lilly And Company Dihydronaphthalene and naphthalene compounds, intermediates, formulations, and methods
CA2213814A1 (en) 1996-08-29 1998-02-28 Henry Uhlman Bryant Naphthalene compounds, intermediates, formulations, and methods
CA2213810C (en) 1996-08-29 2006-06-06 Lewis Dale Pennington Benzo¬b|thiophene compounds, intermediates, processes, compositions and methods
CA2217810A1 (en) * 1996-10-10 1998-04-10 Eli Lilly And Company 2-aryl-3-aminoaryloxynaphthyl compounds, intermediates, compositions and methods
CA2218756A1 (en) 1996-10-25 1998-04-25 Kristin Sue Marron Substituted benzo¢b!thiophene compounds having activity as selective estrogen receptor modulators
BR0312675A (pt) * 2002-07-22 2005-05-03 Lilly Co Eli Composto ou um sal de adição de ácido farmacêutico do mesmo,m e, métodos para tratar endometriose, e para tratar leiomioma uterino

Also Published As

Publication number Publication date
TW200414901A (en) 2004-08-16
HK1078003A1 (en) 2006-03-03
EP1530470B9 (en) 2010-04-07
DE60327931D1 (de) 2009-07-23
EA200500248A1 (ru) 2005-06-30
JP5220800B2 (ja) 2013-06-26
US20080214612A1 (en) 2008-09-04
EP1530470A1 (en) 2005-05-18
US7585977B2 (en) 2009-09-08
AU2003253129B2 (en) 2008-12-11
CO5680445A2 (es) 2006-09-29
CN1668303A (zh) 2005-09-14
NO20050832L (no) 2005-02-16
CR7657A (es) 2005-07-13
CN1668303B (zh) 2010-10-27
ES2326593T3 (es) 2009-10-15
US7399867B2 (en) 2008-07-15
CA2490580C (en) 2012-12-11
ECSP055549A (es) 2005-03-10
HRP20041233A2 (en) 2005-02-28
MXPA05000898A (es) 2005-05-16
IL165745A0 (en) 2006-01-15
JP4656939B2 (ja) 2011-03-23
NZ537138A (en) 2007-11-30
JP2005538089A (ja) 2005-12-15
MY141879A (en) 2010-07-16
WO2004009086A1 (en) 2004-01-29
ATE433322T1 (de) 2009-06-15
TWI314860B (en) 2009-09-21
EA008024B1 (ru) 2007-02-27
EP1530470B1 (en) 2009-06-10
CA2490580A1 (en) 2004-01-29
US20060183736A1 (en) 2006-08-17
JP2010195820A (ja) 2010-09-09
BR0312675A (pt) 2005-05-03
PL374845A1 (en) 2005-11-14
AU2003253129A1 (en) 2004-02-09

Similar Documents

Publication Publication Date Title
PE20040678A1 (es) Moduladores de los receptores selectivos de estrogenos
ATE496620T1 (de) 1h-benzo(f)indazol-5-yl-derivate als selektive glucocorticoid-rezeptor-modulatoren
NO20041504L (no) Lactamderivater som antagonister for humane 11CBY reseptorer.
UA94600C2 (en) Indole sulfonamide modulators of progesterone receptors
DE60204674D1 (de) Retinoid x rezeptormodulatoren
EA200970811A1 (ru) Новые производные бензамида в качестве модуляторов фолликулостимулирующего гормона
DK1408961T3 (da) 2 pyrrolidon-derivater som prostanoide agonister
BR0104834A (pt) Moduladores de receptores de glucocorticóides
BR0206595A (pt) Composto, composição farmacêutica, e uso de um composto
ATE327974T1 (de) Modulatoren des glucocorticoid-rezeptors
NO20071922L (no) Indazoler, benzisokazoler og benzinsotiazoler og anvendelse derav som ostrogene midler
DE602004014772D1 (de) Pyrrol-2,5-dithionderivate als modulatoren des liver-x-rezeptors
DE60233111D1 (de) Glucocorticoid-rezeptoren-modulatoren
ATE447575T1 (de) Selektive spirocyclische glucocorticoid-rezeptor- modulatoren
ATE375985T1 (de) Oxazolylarylpropionsäure derivate und ihre verwendung als ppar agonisten
ATE266400T1 (de) Heterocyclyl sulphonamid derivate
ATE402140T1 (de) Cyclopentyl sulfonamid derivaten
NO20076683L (no) Cyanopyrrol-sulfonamid progesteron reseptormodulatorer og deres anvendelse
ATE448215T1 (de) Selektive östrogen-rezeptor-modulatoren
EA200970189A1 (ru) Пирролидинонанилины как модуляторы прогестероновых рецепторов
EP1782810A3 (en) Selective estrogen receptor modulators containing a phenylsulfonyl group
TH86640A (th) สารปรับตัวรับไซยาโนพรัยโรล-ซัลโฟนาไมด์โปรเจสเตอโรนและการใช้สารนี้

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed